China-New Zealand FTA – Origin Cumulation Pharmaceutical Products

Quelle: https://www.trade.gov/china-new-zealand-fta-pharmaceuticals

The origin cumulation under the Free Trade Agreement between China and New Zealand allows pharmaceutical products manufactured in either country to be considered as originating goods when exported to the other country, creating customs advantages in trade.

Related Terms

You might also be interested in these terms

China-New Zealand FTA – Origin Cumulation Toys

Origin cumulation refers to the provision that allows goods produced in China or New Zealand to be considered originating products of the other party ...

Learn more

CAFTA-DR – Origin Cumulation Pharmaceutical Products

CAFTA-DR – Origin cumulation refers to the mechanism under the Central America Free Trade Agreement – Dominican Republic that allows countries to appl...

Learn more

EFTA–Chile FTA – Origin Cumulation Pharmaceutical Products

The EFTA-Chile Free Trade Agreement allows for origin cumulation for pharmaceutical products, meaning that these products can benefit from the accumul...

Learn more

EFTA–China FTA – Origin Cumulation Pharmaceutical Products

Origin cumulation under the EFTA–China FTA refers to the regulation that allows materials and products from certain EFTA states and China to be aggreg...

Learn more

China-New Zealand FTA – Origin Cumulation Rubber

The term refers to the rules of origin within the Free Trade Agreement between China and New Zealand that allow materials from third countries to be u...

Learn more

China-New Zealand FTA – Origin Cumulation Clothing

Origin cumulation under the China-New Zealand Free Trade Agreement allows for the inclusion of criteria from other FTA partners when determining the c...

Learn more